Business Context and Reporting Period
This Form 8-K is a current report filed by Obalon Therapeutics, Inc. (not Vyome Holdings, Inc.) on April 4, 2017. The filing announces the scheduling of the Company's 2017 Annual Meeting of Stockholders.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a procedural notice regarding corporate governance and does not contain financial statements.
Material Changes
No material financial changes or operational updates are reported in this filing. The document solely addresses the logistics of the upcoming annual meeting.
Guidance, Outlook, and Management Commentary
Annual Meeting Details:
- Date: June 6, 2017
- Time: 8:00 a.m. Pacific Time
- Location: 5421 Avenida Encinas, Suite F, Carlsbad, California 92008
Stockholder Requirements:
- Record Date: April 19, 2017 (holders of record at close of business are entitled to vote).
- Notice Deadline: April 14, 2017 (deadline for stockholders to submit written notice for proposed business or director nominations).
Key Facts for Investor Verification
- Verify the correct registrant name is Obalon Therapeutics, Inc., not Vyome Holdings, Inc.
- Confirm the record date of April 19, 2017, to determine voting eligibility.
- Note the April 14, 2017 deadline for submitting proposals or director nominations.
- Review the Company's Amended and Restated Bylaws for specific requirements regarding notice delivery and content.